Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib
Lasater, E A, Massi, E S, Stecula, A, Politi, J, Tan, S K, Smith, C C, Gunthorpe, M, Holmes, J P, Chehab, F, Sali, A, Shah, N PLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2015.303
Date:
October, 2015
File:
PDF, 1.42 MB
english, 2015